| Financial Year |
March 31 2023 |
| Monetary Funds |
1,074,523,630.31 |
| Held-for-trading Financial Assets |
1,882,807.92 |
| Notes Receivable |
33,036,793.98 |
| Accounts Receivable |
1,461,173,136.61 |
| Advances to Suppliers |
92,693,274.88 |
| Other Receivables |
70,656,139.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
444,618.72 |
| Dividend Receivable |
1,600,000.00 |
| Inventories |
1,323,799,915.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
57,542,959.49 |
| Total Current Assets |
4,228,903,573.68 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
286,840,345.88 |
| Investment Properties |
-- |
| Fixed Assetes |
993,896,137.06 |
| Under-construction Projects |
141,340,189.39 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
528,536,133.40 |
| R&D expenses |
183,635,556.65 |
| Goodwill |
629,946,427.39 |
| Long-Term Deferred and Prepaid Expenses |
25,353,747.36 |
| Deferred Income Tax Assets |
99,379,354.61 |
| Other Non-Current Assets |
88,569,287.99 |
| Sub-Total of Non-Current Assets |
3,359,758,036.74 |
| Total Assets |
7,588,661,610.42 |
| Short-Term Loans |
189,900,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
296,705,756.51 |
| Accounts Payable |
1,101,489,686.54 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
53,796,274.42 |
| Taxes Payable |
28,389,815.70 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
153,920,336.21 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
87,063,346.94 |
| Other Current Liabilities |
70,000,000.00 |
| Sub-Total of Current Liabilities |
2,080,537,418.91 |
| Long-term Loans |
169,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
226,908,199.06 |
| Special Payable |
-- |
| Estimatied Liabilities |
31,823,035.25 |
| Deferred Income Tax Liabilities |
13,767,251.91 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
690,593,679.83 |
| Total Liabilities |
2,771,131,098.74 |
| Paid-In Capital(Or Share Stock) |
512,784,757.00 |
| Capital Surplus |
3,886,553,753.55 |
| Surplus Reserve |
52,799,753.99 |
| LESS:Treasury Stock |
225,607,612.48 |
| Undistributed Profits |
149,149,868.20 |
| Minority Stockholder's Interest |
452,976,878.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,364,553,633.64 |
| Owner's Equity（Stockholder's Equity） |
4,817,530,511.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,588,661,610.42 |
